Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2026-02-26 @ 5:45 PM
Study NCT ID:
NCT00280956
Status:
COMPLETED
Last Update Posted:
2016-06-16
First Post:
2006-01-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Open Label Natalizumab Safety Extension Study for Subjects With Crohn's Disease
Sponsor:
Biogen
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CD351
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |